Detalhe da pesquisa
1.
Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial.
Lancet
; 402(10398): 291-303, 2023 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37285865
2.
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma.
N Engl J Med
; 383(13): 1218-1230, 2020 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32945632
3.
Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma.
Blood
; 137(26): 3616-3628, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33763699
4.
Randomized Phase II Trial of Sapanisertib ± TAK-117 vs. Everolimus in Patients With Advanced Renal Cell Carcinoma After VEGF-Targeted Therapy.
Oncologist
; 27(12): 1048-1057, 2022 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36146944
5.
Plain language summary of results from the JAVELIN Bladder 100 study: avelumab maintenance treatment for advanced urothelial cancer.
Future Oncol
; 18(19): 2361-2371, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35416053
6.
Long survival of patients with metastatic clear cell renal cell carcinoma. Results of real life study of 344 patients.
Int J Cancer
; 146(6): 1643-1651, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31318983
7.
Pomalidomide, cyclophosphamide, and dexamethasone for relapsed multiple myeloma.
Blood
; 132(24): 2555-2563, 2018 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30282798
8.
Apixaban for the prevention of thromboembolism in immunomodulatory-treated myeloma patients: Myelaxat, a phase 2 pilot study.
Am J Hematol
; 94(6): 635-640, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30859608
9.
Prospective study of a web-mediated management of febrile neutropenia related to chemotherapy (Bioconnect).
Support Care Cancer
; 27(6): 2189-2194, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30306327
10.
Totally implantable venous access ports: a prospective long-term study of early and late complications in adult patients with cancer.
Support Care Cancer
; 26(1): 81-89, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28756472
11.
Detecting lung cancer relapse using self-evaluation forms weekly filled at home: the sentinel follow-up.
Support Care Cancer
; 22(1): 79-85, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23995815
12.
Detection of lung cancer relapse using self-reported symptoms transmitted via an internet web-application: pilot study of the sentinel follow-up.
Support Care Cancer
; 22(6): 1467-73, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24414998
13.
First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial.
Nat Med
; 30(1): 257-264, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38049622
14.
A Randomized, Open-label, Cross-over Phase 2 Trial of Darolutamide and Enzalutamide in Men with Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer: Patient Preference and Cognitive Function in ODENZA.
Eur Urol
; 85(3): 274-282, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37271630
15.
Larotaxel with Cisplatin in the first-line treatment of locally advanced/metastatic urothelial tract or bladder cancer: a randomized, active-controlled, phase III trial (CILAB).
Oncology
; 85(4): 208-15, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24080920
16.
Avelumab First-line Maintenance Therapy for Advanced Urothelial Carcinoma: Comprehensive Clinical Subgroup Analyses from the JAVELIN Bladder 100 Phase 3 Trial.
Eur Urol
; 84(1): 95-108, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37121850
17.
Late versus early response and depth of response are associated with improved outcomes in patients with newly diagnosed multiple myeloma enrolled in the TOURMALINE-MM2 trial.
EJHaem
; 4(4): 995-1005, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38024593
18.
Biweekly vs Triweekly Cabazitaxel in Older Patients With Metastatic Castration-Resistant Prostate Cancer: The CABASTY Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 9(12): 1629-1638, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37883073
19.
Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 Study.
Eur Urol
; 84(3): 321-330, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37277275
20.
Cloned IGH VDJ targets as tools for personalized minimal residual disease monitoring in mature lymphoid malignancies; a feasibility study in mantle cell lymphoma by the Groupe Ouest Est d'Etude des Leucémies et Autres Maladies du Sang.
Br J Haematol
; 158(2): 186-197, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22626453